{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "ae2cb230",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np \n",
    "import matplotlib.pyplot as plt \n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "9f9ee40d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug_ID</th>\n",
       "      <th>Drug_Name</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>Active_Ingredients</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Country</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1001</td>\n",
       "      <td>Panacure</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Favipiravir</td>\n",
       "      <td>200mg</td>\n",
       "      <td>Germany</td>\n",
       "      <td>2024-12-24</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1002</td>\n",
       "      <td>Zedafil</td>\n",
       "      <td>Roche</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>5mg</td>\n",
       "      <td>India</td>\n",
       "      <td>2022-09-25</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1003</td>\n",
       "      <td>Ibucare</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>500mg</td>\n",
       "      <td>USA</td>\n",
       "      <td>2022-05-14</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1004</td>\n",
       "      <td>Xanpril</td>\n",
       "      <td>Roche</td>\n",
       "      <td>Favipiravir</td>\n",
       "      <td>500mg</td>\n",
       "      <td>UK</td>\n",
       "      <td>2023-06-07</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1005</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Lupin</td>\n",
       "      <td>Ibuprofen</td>\n",
       "      <td>400mg</td>\n",
       "      <td>Germany</td>\n",
       "      <td>2023-04-21</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>1096</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>Sun Pharma</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-12-17</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>1097</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>GSK</td>\n",
       "      <td>Azithromycin</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-27</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>1098</td>\n",
       "      <td>Zedafil</td>\n",
       "      <td>Cipla</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>200mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-07-13</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>1099</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Moderna</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>500mg</td>\n",
       "      <td>UK</td>\n",
       "      <td>2023-04-21</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>1100</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Amoxicillin</td>\n",
       "      <td>250mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-15</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Drug_ID Drug_Name Manufacturer Active_Ingredients Strength    Country  \\\n",
       "0      1001  Panacure  AstraZeneca        Favipiravir    200mg    Germany   \n",
       "1      1002   Zedafil        Roche         Lisinopril      5mg      India   \n",
       "2      1003   Ibucare       Pfizer                NaN    500mg        USA   \n",
       "3      1004   Xanpril        Roche        Favipiravir    500mg         UK   \n",
       "4      1005  Ventomax        Lupin          Ibuprofen    400mg    Germany   \n",
       "..      ...       ...          ...                ...      ...        ...   \n",
       "95     1096   Azitron   Sun Pharma         Lisinopril    100mg  Australia   \n",
       "96     1097   Azitron          GSK       Azithromycin    100mg     Canada   \n",
       "97     1098   Zedafil        Cipla         Lisinopril    200mg  Australia   \n",
       "98     1099  Ventomax      Moderna         Lisinopril    500mg         UK   \n",
       "99     1100  Ventomax  AstraZeneca        Amoxicillin    250mg     Canada   \n",
       "\n",
       "   Approval_Date    Status  \n",
       "0     2024-12-24  Rejected  \n",
       "1     2022-09-25  Rejected  \n",
       "2     2022-05-14  Approved  \n",
       "3     2023-06-07  Approved  \n",
       "4     2023-04-21  Rejected  \n",
       "..           ...       ...  \n",
       "95    2024-12-17  Approved  \n",
       "96    2022-12-27   Pending  \n",
       "97    2024-07-13   Pending  \n",
       "98    2023-04-21   Pending  \n",
       "99    2022-12-15   Pending  \n",
       "\n",
       "[100 rows x 8 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Reading the csv data \n",
    "df = pd.read_csv(r\"C:\\Users\\deepe\\Downloads\\healthcare_drug_registration.csv\")\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "258e93b7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug_ID</th>\n",
       "      <th>Drug_Name</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>Active_Ingredients</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Country</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>100.000000</td>\n",
       "      <td>96</td>\n",
       "      <td>100</td>\n",
       "      <td>92</td>\n",
       "      <td>100</td>\n",
       "      <td>100</td>\n",
       "      <td>91</td>\n",
       "      <td>100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>NaN</td>\n",
       "      <td>9</td>\n",
       "      <td>9</td>\n",
       "      <td>9</td>\n",
       "      <td>7</td>\n",
       "      <td>6</td>\n",
       "      <td>87</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Sildenafil</td>\n",
       "      <td>500mg</td>\n",
       "      <td>USA</td>\n",
       "      <td>2023-11-17</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>NaN</td>\n",
       "      <td>15</td>\n",
       "      <td>14</td>\n",
       "      <td>17</td>\n",
       "      <td>23</td>\n",
       "      <td>19</td>\n",
       "      <td>2</td>\n",
       "      <td>34</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>1050.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>29.011492</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>1001.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>1025.750000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>1050.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>1075.250000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>1100.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            Drug_ID Drug_Name Manufacturer Active_Ingredients Strength  \\\n",
       "count    100.000000        96          100                 92      100   \n",
       "unique          NaN         9            9                  9        7   \n",
       "top             NaN  Ventomax       Pfizer         Sildenafil    500mg   \n",
       "freq            NaN        15           14                 17       23   \n",
       "mean    1050.500000       NaN          NaN                NaN      NaN   \n",
       "std       29.011492       NaN          NaN                NaN      NaN   \n",
       "min     1001.000000       NaN          NaN                NaN      NaN   \n",
       "25%     1025.750000       NaN          NaN                NaN      NaN   \n",
       "50%     1050.500000       NaN          NaN                NaN      NaN   \n",
       "75%     1075.250000       NaN          NaN                NaN      NaN   \n",
       "max     1100.000000       NaN          NaN                NaN      NaN   \n",
       "\n",
       "       Country Approval_Date    Status  \n",
       "count      100            91       100  \n",
       "unique       6            87         3  \n",
       "top        USA    2023-11-17  Rejected  \n",
       "freq        19             2        34  \n",
       "mean       NaN           NaN       NaN  \n",
       "std        NaN           NaN       NaN  \n",
       "min        NaN           NaN       NaN  \n",
       "25%        NaN           NaN       NaN  \n",
       "50%        NaN           NaN       NaN  \n",
       "75%        NaN           NaN       NaN  \n",
       "max        NaN           NaN       NaN  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.describe(include = 'all')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cc2674a2",
   "metadata": {},
   "source": [
    "# Data Cleaning"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "38fe6670",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Drug_Name'] = df['Drug_Name'].replace('',pd.NA)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "fed1f15c",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Active_Ingredients'] = df['Active_Ingredients'].replace('',pd.NA)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "08000c6f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug_ID</th>\n",
       "      <th>Drug_Name</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>Active_Ingredients</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Country</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>1096</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>Sun Pharma</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-12-17</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>1097</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>GSK</td>\n",
       "      <td>Azithromycin</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-27</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>1098</td>\n",
       "      <td>Zedafil</td>\n",
       "      <td>Cipla</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>200mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-07-13</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>1099</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Moderna</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>500mg</td>\n",
       "      <td>UK</td>\n",
       "      <td>2023-04-21</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>1100</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Amoxicillin</td>\n",
       "      <td>250mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-15</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Drug_ID Drug_Name Manufacturer Active_Ingredients Strength    Country  \\\n",
       "95     1096   Azitron   Sun Pharma         Lisinopril    100mg  Australia   \n",
       "96     1097   Azitron          GSK       Azithromycin    100mg     Canada   \n",
       "97     1098   Zedafil        Cipla         Lisinopril    200mg  Australia   \n",
       "98     1099  Ventomax      Moderna         Lisinopril    500mg         UK   \n",
       "99     1100  Ventomax  AstraZeneca        Amoxicillin    250mg     Canada   \n",
       "\n",
       "   Approval_Date    Status  \n",
       "95    2024-12-17  Approved  \n",
       "96    2022-12-27   Pending  \n",
       "97    2024-07-13   Pending  \n",
       "98    2023-04-21   Pending  \n",
       "99    2022-12-15   Pending  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "2746d0c8",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Approval_Date'] = pd.to_datetime(df['Approval_Date'], errors='coerce')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c6acab79",
   "metadata": {},
   "source": [
    "Filling the Mising values "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "2817df79",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Drug_Name'].fillna(\"Unknown\", inplace=True)\n",
    "df['Active_Ingredients'].fillna(\"Not Specified\", inplace=True)\n",
    "df['Approval_Date'].fillna(method='ffill', inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "86c3941e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug_ID</th>\n",
       "      <th>Drug_Name</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>Active_Ingredients</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Country</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1001</td>\n",
       "      <td>Panacure</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Favipiravir</td>\n",
       "      <td>200mg</td>\n",
       "      <td>Germany</td>\n",
       "      <td>2024-12-24</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1002</td>\n",
       "      <td>Zedafil</td>\n",
       "      <td>Roche</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>5mg</td>\n",
       "      <td>India</td>\n",
       "      <td>2022-09-25</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1003</td>\n",
       "      <td>Ibucare</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Not Specified</td>\n",
       "      <td>500mg</td>\n",
       "      <td>USA</td>\n",
       "      <td>2022-05-14</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1004</td>\n",
       "      <td>Xanpril</td>\n",
       "      <td>Roche</td>\n",
       "      <td>Favipiravir</td>\n",
       "      <td>500mg</td>\n",
       "      <td>UK</td>\n",
       "      <td>2023-06-07</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1005</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Lupin</td>\n",
       "      <td>Ibuprofen</td>\n",
       "      <td>400mg</td>\n",
       "      <td>Germany</td>\n",
       "      <td>2023-04-21</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>1096</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>Sun Pharma</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-12-17</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>1097</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>GSK</td>\n",
       "      <td>Azithromycin</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-27</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>1098</td>\n",
       "      <td>Zedafil</td>\n",
       "      <td>Cipla</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>200mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-07-13</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>1099</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Moderna</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>500mg</td>\n",
       "      <td>UK</td>\n",
       "      <td>2023-04-21</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>1100</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Amoxicillin</td>\n",
       "      <td>250mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-15</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Drug_ID Drug_Name Manufacturer Active_Ingredients Strength    Country  \\\n",
       "0      1001  Panacure  AstraZeneca        Favipiravir    200mg    Germany   \n",
       "1      1002   Zedafil        Roche         Lisinopril      5mg      India   \n",
       "2      1003   Ibucare       Pfizer      Not Specified    500mg        USA   \n",
       "3      1004   Xanpril        Roche        Favipiravir    500mg         UK   \n",
       "4      1005  Ventomax        Lupin          Ibuprofen    400mg    Germany   \n",
       "..      ...       ...          ...                ...      ...        ...   \n",
       "95     1096   Azitron   Sun Pharma         Lisinopril    100mg  Australia   \n",
       "96     1097   Azitron          GSK       Azithromycin    100mg     Canada   \n",
       "97     1098   Zedafil        Cipla         Lisinopril    200mg  Australia   \n",
       "98     1099  Ventomax      Moderna         Lisinopril    500mg         UK   \n",
       "99     1100  Ventomax  AstraZeneca        Amoxicillin    250mg     Canada   \n",
       "\n",
       "   Approval_Date    Status  \n",
       "0     2024-12-24  Rejected  \n",
       "1     2022-09-25  Rejected  \n",
       "2     2022-05-14  Approved  \n",
       "3     2023-06-07  Approved  \n",
       "4     2023-04-21  Rejected  \n",
       "..           ...       ...  \n",
       "95    2024-12-17  Approved  \n",
       "96    2022-12-27   Pending  \n",
       "97    2024-07-13   Pending  \n",
       "98    2023-04-21   Pending  \n",
       "99    2022-12-15   Pending  \n",
       "\n",
       "[100 rows x 8 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "0f18cdb5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Standardize strength units\n",
    "df['Strength'] = df['Strength'].str.lower().str.strip()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "85f0d655",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug_ID</th>\n",
       "      <th>Drug_Name</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>Active_Ingredients</th>\n",
       "      <th>Strength</th>\n",
       "      <th>Country</th>\n",
       "      <th>Approval_Date</th>\n",
       "      <th>Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1001</td>\n",
       "      <td>Panacure</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Favipiravir</td>\n",
       "      <td>200mg</td>\n",
       "      <td>Germany</td>\n",
       "      <td>2024-12-24</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1002</td>\n",
       "      <td>Zedafil</td>\n",
       "      <td>Roche</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>5mg</td>\n",
       "      <td>India</td>\n",
       "      <td>2022-09-25</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1003</td>\n",
       "      <td>Ibucare</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Not Specified</td>\n",
       "      <td>500mg</td>\n",
       "      <td>USA</td>\n",
       "      <td>2022-05-14</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1004</td>\n",
       "      <td>Xanpril</td>\n",
       "      <td>Roche</td>\n",
       "      <td>Favipiravir</td>\n",
       "      <td>500mg</td>\n",
       "      <td>UK</td>\n",
       "      <td>2023-06-07</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1005</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Lupin</td>\n",
       "      <td>Ibuprofen</td>\n",
       "      <td>400mg</td>\n",
       "      <td>Germany</td>\n",
       "      <td>2023-04-21</td>\n",
       "      <td>Rejected</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>1096</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>Sun Pharma</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-12-17</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>1097</td>\n",
       "      <td>Azitron</td>\n",
       "      <td>GSK</td>\n",
       "      <td>Azithromycin</td>\n",
       "      <td>100mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-27</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>1098</td>\n",
       "      <td>Zedafil</td>\n",
       "      <td>Cipla</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>200mg</td>\n",
       "      <td>Australia</td>\n",
       "      <td>2024-07-13</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>1099</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>Moderna</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>500mg</td>\n",
       "      <td>UK</td>\n",
       "      <td>2023-04-21</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>1100</td>\n",
       "      <td>Ventomax</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Amoxicillin</td>\n",
       "      <td>250mg</td>\n",
       "      <td>Canada</td>\n",
       "      <td>2022-12-15</td>\n",
       "      <td>Pending</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Drug_ID Drug_Name Manufacturer Active_Ingredients Strength    Country  \\\n",
       "0      1001  Panacure  AstraZeneca        Favipiravir    200mg    Germany   \n",
       "1      1002   Zedafil        Roche         Lisinopril      5mg      India   \n",
       "2      1003   Ibucare       Pfizer      Not Specified    500mg        USA   \n",
       "3      1004   Xanpril        Roche        Favipiravir    500mg         UK   \n",
       "4      1005  Ventomax        Lupin          Ibuprofen    400mg    Germany   \n",
       "..      ...       ...          ...                ...      ...        ...   \n",
       "95     1096   Azitron   Sun Pharma         Lisinopril    100mg  Australia   \n",
       "96     1097   Azitron          GSK       Azithromycin    100mg     Canada   \n",
       "97     1098   Zedafil        Cipla         Lisinopril    200mg  Australia   \n",
       "98     1099  Ventomax      Moderna         Lisinopril    500mg         UK   \n",
       "99     1100  Ventomax  AstraZeneca        Amoxicillin    250mg     Canada   \n",
       "\n",
       "   Approval_Date    Status  \n",
       "0     2024-12-24  Rejected  \n",
       "1     2022-09-25  Rejected  \n",
       "2     2022-05-14  Approved  \n",
       "3     2023-06-07  Approved  \n",
       "4     2023-04-21  Rejected  \n",
       "..           ...       ...  \n",
       "95    2024-12-17  Approved  \n",
       "96    2022-12-27   Pending  \n",
       "97    2024-07-13   Pending  \n",
       "98    2023-04-21   Pending  \n",
       "99    2022-12-15   Pending  \n",
       "\n",
       "[100 rows x 8 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "9e86bd10",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Manufacturer\n",
       "Pfizer         14\n",
       "Sun Pharma     14\n",
       "Roche          13\n",
       "AstraZeneca    12\n",
       "Novartis       11\n",
       "Lupin          10\n",
       "Moderna        10\n",
       "Cipla           9\n",
       "GSK             7\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Manufacturer'].value_counts() # checking the count of the Manufacturer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "96f8d5a5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Status\n",
       "Rejected    34\n",
       "Approved    33\n",
       "Pending     33\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "2cbdc589",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Visualizations\n",
    "plt.figure(figsize=(10, 5))\n",
    "sns.countplot(data=df, x='Status', order=df['Status'].value_counts().index)\n",
    "plt.title(\"Drug Approval Status Distribution\")\n",
    "plt.xlabel(\"Status\")\n",
    "plt.ylabel(\"Count\")\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "666ee1ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(12, 6))\n",
    "df['Approval_Date'].dt.year.value_counts().sort_index().plot(kind='bar')\n",
    "plt.title(\"Drug Approvals by Year\")\n",
    "plt.xlabel(\"Year\")\n",
    "plt.ylabel(\"Number of Approvals\")\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b13e6982",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
